News Daily News FDA Proposes Simplified Front-of-Package Nutrition Labels on Foods Todd Neale January 14, 2025
News Daily News Survival After Bystander CPR in OHCA Varies by Race/Ethnicity, Sex Caitlin E. Cox August 12, 2024
News Daily News Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why? L.A. McKeown September 11, 2023
News Conference News ESC 2023 ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD Michael O'Riordan September 05, 2023
News Daily News Drop in Kawasaki Disease During COVID-19 Provides Clues to Pathogenesis Todd Neale October 21, 2022
News Conference News ACC 2022 Bystander CPR for Cardiac Arrest Woefully Rare in Black and Hispanic Individuals L.A. McKeown March 24, 2022
News Daily News AHA: More Screening Needed to Catch Myocardial Injury After Noncardiac Surgery Yael L. Maxwell October 04, 2021
News Daily News Statins Not Linked to Dementia or Memory Changes: ASPREE Michael O'Riordan June 21, 2021
News Daily News Paper Probes Physical Activity Paradox and Perils of ‘Privileged’ Advice Shelley Wood April 15, 2021
News Features Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery Todd Neale July 29, 2020
News Daily News FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat Shelley Wood February 22, 2019
News Daily News Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review Caitlin E. Cox January 11, 2019
News Conference News SCCT 2018 Think Like a Patient: Rationale and Resources for Shared Decision-Making in Cardiology Yael L. Maxwell July 13, 2018
News Daily News All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout Caitlin E. Cox June 19, 2018
News Conference News ACC 2018 Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Conference News ACC 2018 ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018
Presentation ACC 2018 Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial) Presenter: William B. White March 11, 2018
News Industry News Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death October 02, 2017